An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
|Effective start/end date
|2/1/17 → 7/31/20
- SANOFI-AVENTIS US
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.